drugset / Trial / NCT01367262
Disposition of Carbon-14-Labeled LY2886721 ([^14C]-LY2886721) Following Oral Administration in Healthy Human Participants
NaSingle-groupOpen-labelOther
Summary
This open-label study is being conducted to determine the metabolism and physiological disposition of radiolabeled LY2886721 after a single dose in healthy male participants.
Timeline
- Start
- 2011-06
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2886721 | Small molecule | 25 mg | Oral |
Indications
No indication recorded.